Short- and Long-Term Outcomes After Stent-Assisted Percutaneous Treatment of Saphenous Vein Grafts in the Drug-Eluting Stent Era

American Journal of Cardiology

Volumn 101, Issue 1, 2008, Pages 63-68

  Pucelikova, Tereza ^a   Mehran, Roxana ^a   Kirtane, Ajay J ^a   Kim, Young Hak ^a   Fahy, Martin ^a   Weisz, Giora ^a   Lansky, Alexandra J ^a   Moussa, Issam ^a   Gray, William A ^a   Collins, Michael B ^a   Kodali, Susheel K ^a   Stone, Gregg W ^a   Moses, Jeffrey W ^a   Leon, Martin B ^a   Dangas, George ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEVICE THERAPY; DRUG ELUTING STENT; EMBOLISM; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HEART MUSCLE NECROSIS; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SAPHENOUS VEIN GRAFT; STENT; THROMBOSIS; THROMBUS; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RETREATMENT; SAPHENOUS VEIN; SIROLIMUS; STENTS; THROMBOSIS;

EID: 37349066747     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.048     Document Type: Article

References (23)

1. Bourassa M.G., Fisher L.D., Campeau L., Gillespie M.J., McConney M., and Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 72 suppl (1985) V71-V78
2. Shaia N., and Heuser R.R. Distal embolic protection for SVG interventions: can we afford not to use it?. J Interv Cardiol 18 (2005) 481-484
3. Silva J.A., and White C.J. Percutaneous intervention of old degenerated saphenous vein grafts. Int J Cardiovasc Intervent 4 (2001) 187-194
4. Watson P.S., Hadjipetrou P., Cox S.V., Pyne C.T., Gossman D.E., Piemonte T.C., and Eisenhauer A.C. Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts. Am J Cardiol 83 (1999) 1018-1021
5. Hanekamp C.E., Koolen J.J., Den Heijer P., Schalij M.J., Piek J.J., Bar F.W., De Scheerder I., Bonnier H.J., and Pijls N.H. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: the Venestent study. Catheter Cardiovasc Interv 60 (2003) 452-457
6. Savage M.P., Douglas Jr. J.S., Fischman D.L., Pepine C.J., King III S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., and Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 337 (1997) 740-747
7. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., and Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
8. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
9. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Convens C., Bruining N., Van den Branden F., and Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48 (2006) 2423-2431
10. Wong S.C., Baim D.S., Schatz R.A., Teirstein P.S., King III S.B., Curry Jr. R.C., Heuser R.R., Ellis S.G., Cleman M.W., Overlie P., et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 26 (1995) 704-712
11. Fenton S.H., Fischman D.L., Savage M.P., Schatz R.A., Leon M.B., Baim D.S., King S.B., Heuser R.R., Curry Jr. R.C., Rake R.C., et al. Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. Am J Cardiol 74 (1994) 1187-1191
12. Ahmed J.M., Dangas G., Lansky A.J., Mehran R., Hong M.K., Mintz G.S., Pichard A.D., Satler L.F., Kent K.M., Stone G.W., and Leon M.B. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting. Am J Cardiol 87 (2001) 401-405
13. Brener S.J., Ellis S.G., Apperson-Hansen C., Leon M.B., and Topol E.J. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol 79 (1997) 13-18
14. Stankovic G., Colombo A., Presbitero P., van den Branden F., Inglese L., Cernigliaro C., Niccoli L., Bartorelli A.L., Rubartelli P., Reifart N., et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 108 (2003) 37-42
15. Turco M.A., Buchbinder M., Popma J.J., Weissman N.J., Mann T., Doucet S., Johnson Jr. W.L., Greenberg J.D., Leadley K., and Russell M.E. Pivotal, randomized U.S. study of the Symbiot trade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Catheter Cardiovasc Interv 68 (2006) 379-388
16. Stone G.W., Goldberg S., Mehran R., O'Shaughnessy C., Midei M., Siegel R., George B., Salter S., Rainzer A., Negoita M., et al. A prospective, randomized U.S. trial of the PTFE-covered JOSTENT for the treatment of diseased saphenous vein grafts: the BARRICADE trial. J Am Coll Cardiol 45 suppl A (2005) 27A
17. Chu W.W., Kuchulakanti P.K., Wang B., Clavijo L.C., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., and Waksman R. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention. J Interv Cardiol 19 (2006) 121-125
18. Tsuchida K., Ong A.T., Aoki J., van Mieghem C.A., Rodriguez-Granillo G.A., Valgimigli M., Sianos G., Regar E., McFadden E.P., van der Giessen W.J., et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 96 (2005) 395-398
19. Lee M.S., Shah A.P., Aragon J., Jamali A., Dohad S., Kar S., and Makkar R.R. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 66 (2005) 507-511
20. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994
21. Waksman R., Weintraub W.S., Ghazzal Z., Scott N.A., Shen Y., King III S.B., and Douglas Jr. J.S. Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J 134 (1997) 274-281
22. Ashfaq S., Ghazzal Z., Douglas J.S., Morris D.C., Veledar E., and Weintraub W.S. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era. J Invasive Cardiol 18 (2006) 100-105
23. CASS Investigators. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310 (1984) 750-758